PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION

Common anti-inflammatory coaxes liver cancer cells to commit suicide

2011-05-17
(Press-News.org) COLUMBUS, Ohio – The anti-inflammatory drug celecoxib, known by the brand name Celebrex, triggers liver cancer cell death by reacting with a protein in a way that makes those cells commit suicide, according to a new study.

Researchers also found that the combination of celecoxib with each of two chemotherapy drugs killed more liver cancer cells in culture, making those combinations more effective than either drug on its own.

"Each chemotherapy drug alone will reduce the growth of cancer cells, but when each single drug is combined with Celebrex, a greater growth suppression effect was observed," said Jiayuh Lin, senior author of the study and an associate professor of pediatrics at Ohio State University. "For clinicians, this research suggests the possibility of a new therapeutic strategy."

Celecoxib has this effect by acting on STAT3, a gene inside liver cancer cells that, when activated, allows those cancer cells to resist the effects of chemotherapy drugs. The researchers determined that the celecoxib molecule binds to STAT3 on so-called "hot spots," effectively blocking its ability to function.

Powerful computing techniques were employed before the researchers ever considered celecoxib as a potential treatment for cancer. Celebrex is a nonsteroidal anti-inflammatory drug, or NSAID, and a Cox-2 inhibitor, meaning it helps control inflammation by inhibiting an enzyme known as cyclooxygenase-2. It is most commonly prescribed to treat the pain of arthritis.

Chenglong Li, an assistant professor of medicinal chemistry and pharmacognosy at Ohio State, has developed computer simulations to identify optimal drug fragment combinations that attach simultaneously to proteins in ways that block the proteins' functions. By searching a database of existing federally approved drugs, he found that celecoxib was structurally similar to a template molecule that he had determined would most effectively bind to STAT3 and inhibit its function.

"Normally, STAT3 is persistently activated in cancer cells. If you have a good molecule that sticks to STAT3, it will prevent its activation," Li said. And when STAT3 is inhibited, cellular survival pathways are blocked that cause the cancer cell to chop itself up and die.

The research appears online and is scheduled for later print publication in the journal Cancer Prevention Research.

The biological portion of the study further defined the role of a pro-inflammatory protein in liver cancer's development. The protein, called interleukin-6, or IL-6, is a cytokine, a chemical messenger that causes inflammation, which can have both beneficial and damaging effects in the body. Previous research by other scientists has shown that high levels of IL-6 in the blood are associated with hepatocellular carcinoma, the most common type of liver cancer.

Lin and colleagues determined that IL-6 initiates a chemical reaction called phosphorylation of STAT3. That reaction activates STAT3 inside liver cancer cells, where STAT3 in turn activates at least three other known genes that allow the cells to resist the effects of chemotherapy.

The scientists treated five different types of hepatocellular carcinoma cells with two different doses of celecoxib for two hours, and followed by giving them IL-6 for 30 minutes. The pre-treatment with the lower dose of celecoxib inhibited IL-6's ability to start the reaction that activates STAT3. The higher dose blocked STAT3 altogether.

The researchers then treated a line of liver cancer cells with celecoxib in combination with two chemotherapy drugs: doxorubicin, which is used to treat breast, ovarian, gastric, thyroid and several other cancers, and sorafenib, which is the only chemotherapy medication approved by the Food and Drug Administration for liver cancer treatment. Its brand name is Nexavar.

With both drugs, the addition of celecoxib treatment reduced the number of viable liver cancer cells by anywhere from approximately 50 percent to more than 90 percent, depending on the doses. The combination of celecoxib and sorafenib also significantly limited the cancer cells' ability to form colonies, a key element of tumor growth and survival after the drug treatment.

"Because liver cancer has a very low five-year survival rate, it is most likely that even sorafenib alone may not be effective to cure the cancer," said Lin, also an investigator in Ohio State's Comprehensive Cancer Center and the Center for Childhood Cancer at Nationwide Children's Hospital. "We hope that using both drugs together could be more effective. Both celecoxib and sorafenib are already approved by the FDA, so we think this combined treatment should be able to be used in the clinic pretty quickly."

The fifth most common cancer in humans, liver cancer remains one of the most difficult to successfully treat. Patients' overall five-year survival rate is about 10 percent, according to the American Cancer Society.

These experiments were conducted in cell cultures. Further testing would be needed to determine celecoxib's effectiveness in human cancers, Lin noted.

And the powerful computational work led by Li, also an investigator in Ohio State's Comprehensive Cancer Center, is likely to lead to the development of new molecules with even more precise structural relationships with the proteins they are designed to block.

Li's method is called Multiple Ligand Simultaneous Docking. In this work, he used computer simulations to identify "hot spots" on the STAT3 protein – tiny pockets to which molecules could most successfully attach to inhibit the protein's activity. He then searched through drug banks containing more than 7,500 existing and experimental medications to find the most suitable molecular fragments that could be pieced together to produce a new molecule shaped in such a way that it would fit into those pockets.

After designing a template molecule that would most effectively bind to STAT3, he compared that template to the 1,400 federally approved drugs already on the market.

"Celecoxib is almost identical to the molecule template. It attaches to STAT3 in three places. We can optimize celecoxib, and that is expected to come soon. But applying our technique to find those pieces and determining that they come from an existing drug makes the discovery process much faster," said Li, a key co-author of the paper and frequent research collaborator with Lin.

Li has termed this approach as in silico (computer-driven) drug repositioning or repurposing.

The discovery that celecoxib can bind to STAT3 also appears to apply to other cancers. Both Lin and Li were key authors on a recent paper that suggested that celecoxib's ability to block STAT3's function might also make it effective as a treatment for rhabdomyosarcoma, the most common soft tissue cancer in children and adolescents. This research was published in the April 15 issue of the journal Biochemical and Biophysical Research Communications.

###

Co-authors of the liver cancer and rhabdomyosarcoma studies include Yan Liu, Aiguo Liu and Suzanne Reed of the Center for Childhood Cancer at Nationwide Children's Hospital (Aiguo Liu is also affiliated with Tongji Hospital at Huazhong University of Science and Technology in Wuhan, China); and Huameng Li of Ohio State's Division of Medicinal Chemistry and Pharmacognosy and the Biophysics Graduate Program.

This work was supported by grants from the National Institutes of Health and the Department of Defense Congressionally Directed Medical Research Programs.

Contact: Jiayuh Lin, (614) 722-5086; lin.674@osu.edu or Chenglong Li, (614) 247-8786; cli@pharmacy.ohio-state.edu

Written by Emily Caldwell, (614) 292-8310; caldwell.151@osu.edu

END



ELSE PRESS RELEASES FROM THIS DATE:

Patterns of ancient croplands give insight into early Hawaiian society, research shows

2011-05-17
COLUMBUS, Ohio – A pattern of earthen berms, spread across a northern peninsula of the big island of Hawaii, is providing archeologists with clues to exactly how residents farmed in paradise long before Europeans arrived at the islands. The findings suggest that simple, practical decisions made by individual households were eventually adopted by the ruling class as a means to improve agricultural productivity. The research was reported in the latest issue of the journal Proceedings of the National Academy of Sciences. "Archeologically, this kind of research is really ...

Sleepiness in children linked to obesity, asthma

2011-05-17
Obese, asthmatic, anxious or depressed children are more likely to experience excessive daytime sleepiness, or EDS, according to Penn State College of Medicine sleep researchers. "Although EDS in children is commonly assumed by physicians and the public to be the result of sleep-disordered breathing or inadequate sleep, our data suggest that EDS in young children is more strongly associated with obesity and mood issues as it is in adults," said Edward Bixler, Ph.D., professor of psychiatry and vice chair of research, Sleep Research and Treatment Center. EDS is the inability ...

Zebrafish regrow fins using multiple cell types, not identical stem cells

Zebrafish regrow fins using multiple cell types, not identical stem cells
2011-05-17
What does it take to regenerate a limb? Biologists have long thought that organ regeneration in animals like zebrafish and salamanders involved stem cells that can generate any tissue in the body. But new research suggests that multiple cell types are needed to regrow the complete organ, at least in zebrafish. Researchers at Washington University School of Medicine in St. Louis have shown that cells capable of regenerating a zebrafish fin do not revert to stem cells that can form any tissue. Instead, the individual cells retain their original identities and only give ...

Study finds many gastroenterologists unaware of appropriate immunizations for IBD patients

2011-05-17
(Boston) – Researchers from Boston University School of Medicine (BUSM), along with clinicians from Boston Medical Center (BMC), have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease (IBD) patient is limited. These findings, which currently appear on-line in Inflammatory Bowel Diseases, may be the primary reason why the majority of gastroenterologists believe that the primary care provider (PCP) should be responsible for vaccinations. Current therapy for IBD patients often involves agents that suppress ...

Dr. Richard G. Davis of Precision Eye Care Brings Advanced Technology to Laser Refractive Cataract Surgery to Long Island with the Alcon LenSx Femtosecond Laser

2011-05-17
Island Eye Surgicenter is only the fourth surgical facility to acquire this advanced technology in the US. Island Eye Surgicenter located in Carle Place is unique in that it focuses on the surgical care and treatment of eye disorders and specializes in the most advanced laser cataract surgery on Long Island. Cataract surgery is one of the most common and safest surgeries performed in the US today. The Alcon LenSx Femtosecond Laser gives the surgeon precision and reliability vastly improving patient outcomes.This new procedure is extraordinary, and with this new technology, ...

Poisonous tears

Poisonous tears
2011-05-17
For years Professor Leo von Hemmen, a biophysicist at the TU Muenchen, and Professor Bruce Young, a biologist at the University of Massachusetts Lowell, have been researching the sense of hearing in snakes. While discussing the toxicity of their snakes, it dawned on them that only few snakes inject their venom into their victims' bodies using hollow poison fangs. Yet, even though the vast majority of poisonous reptiles lack hollow fangs, they are effective predators. Only around one seventh of all poisonous snakes, like the rattlesnake, rely on the trick with the hollow ...

U of T researchers find link between childhood physical abuse, chronic fatigue syndrome

2011-05-17
TORONTO, ON – Childhood physical abuse is associated with significantly elevated rates of functional somatic syndromes such as chronic fatigue syndrome, fibromyalgia and multiple chemical sensitivities among women, according to new findings by University of Toronto researchers. The research will be published in this month's issue of the Journal of Aggression, Maltreatment & Trauma. "Women who reported they had been physically abused as children have twice the odds of chronic fatigue syndrome and multiple chemical sensitivities, and 65 per cent higher odds of fibromyalgia" ...

London Accountancy Firm Reports Surge in Demand for Business Plan Services During Economic Recovery

London Accountancy Firm Reports Surge in Demand for Business Plan Services During Economic Recovery
2011-05-17
Wisteria Ltd, a chartered accountancy firm based in Edgware, London, has this week shed some light on recent successes, reporting that the popular Wisteria business plan service is enjoying some of its greatest success to date. Many would have anticipated that in a time of financial uncertainty, many new businesses ideas would be held off for more prosperous times, but it seems this is not the case. An increasing number of entrepreneurs are choosing now as the time to make their start-up idea a reality. Wisteria have benefited greatly from the trend, with their ...

Low-dose sorafenib may improve therapy for head and neck cancer

2011-05-17
COLUMBUS, Ohio – Adding low doses of the targeted agent sorafenib to the chemotherapy and radiation now often used to treat head and neck cancer might significantly improve patient care and quality of life, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). The findings suggest that adding sorafenib would maintain treatment efficacy while permitting the use of lower doses of chemotherapy and radiation and decreasing the treatment's harsh ...

Cell rigidity linked to activity in proteins associated with cancer

2011-05-17
Chapel Hill, NC – An unusual collaboration between cell and developmental biologists and physicists at UNC-Chapel Hill is providing insights into the relationship between the physical properties of cells and the signals that influence cell behavior. In a paper published online yesterday in the journal Nature Cell Biology, a team led by Keith Burridge, PhD, Kenan distinguished professor of cell and developmental biology and a member of UNC Lineberger Comprehensive Cancer Center, and Richard Superfine, PhD, Taylor-Williams distinguished professor of physics and astronomy, ...

LAST 30 PRESS RELEASES:

Scientists model 'true prevalence' of COVID-19 throughout pandemic

New breakthrough to help immune systems in the fight against cancer

Through the thin-film glass, researchers spot a new liquid phase

Administering opioids to pregnant mice alters behavior and gene expression in offspring

Brain's 'memory center' needed to recognize image sequences but not single sights

Safety of second dose of mRNA COVID-19 vaccines after first-dose allergic reactions

Changes in disparities in access to care, health after Medicare eligibility

Use of high-risk medications among lonely older adults

65+ and lonely? Don't talk to your doctor about another prescription

Exosome formulation developed to deliver antibodies for choroidal neovascularization therapy

Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose

Plant root-associated bacteria preferentially colonize their native host-plant roots

Rare inherited variants in previously unsuspected genes may confer significant risk for autism

International experts call for a unified public health response to NAFLD and NASH epidemic

International collaboration of scientists rewrite the rulebook of flowering plant genetics

Improving air quality reduces dementia risk, multiple studies suggest

Misplaced trust: When trust in science fosters pseudoscience

Two types of blood pressure meds prevent heart events equally, but side effects differ

New statement provides path to include ethnicity, ancestry, race in genomic research

Among effective antihypertensive drugs, less popular choice is slightly safer

Juicy past of favorite Okinawan fruit revealed

Anticipate a resurgence of respiratory viruses in young children

Anxiety, depression, burnout rising as college students prepare to return to campus

Goal-setting and positive parent-child relationships reduce risk of youth vaping

New research identifies cancer types with little survival improvements in adolescents and young adul

Oncotarget: Replication-stress sensitivity in breast cancer cells

Oncotarget: TERT and its binding protein: overexpression of GABPA/B in gliomas

Development of a novel technology to check body temperature with smartphone camera

The mechanics of puncture finally explained

Extreme heat, dry summers main cause of tree death in Colorado's subalpine forests

[Press-News.org] Common anti-inflammatory coaxes liver cancer cells to commit suicide